High mortality in patients with Mycobacterium avium complex lung disease: a systematic review

R Diel, M Lipman, W Hoefsloot - BMC infectious diseases, 2018 - Springer
Background The incidence of nontuberculous mycobacterial (NTM) pulmonary disease
caused by Mycobacterium avium complex (MAC) in apparently immune-competent people is …

[PDF][PDF] Treatment of Mycobacterium avium complex pulmonary disease

YS Kwon, WJ Koh, CL Daley - Tuberculosis and respiratory …, 2019 - synapse.koreamed.org
The pathogen Mycobacterium avium complex (MAC) is the most common cause of
nontuberculous mycobacterial pulmonary disease worldwide. The decision to initiate long …

[HTML][HTML] Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease

KM Pennington, A Vu, D Challener, CG Rivera… - Journal of Clinical …, 2021 - Elsevier
Non-tuberculous mycobacteria (NTM) is a collective name given to a group of more than 190
species of Mycobacterium. The clinical presentation for most NTM infections is non-specific …

The factors associated with mortality and progressive disease of nontuberculous mycobacterial lung disease: a systematic review and meta-analysis

H Hwang, JK Lee, EY Heo, DK Kim, HW Lee - Scientific reports, 2023 - nature.com
This systematic review and meta-analysis aimed to comprehensively evaluate the factors
associated with mortality and progressive disease in NTM-LD patients. We conducted a …

Microbiological cure at treatment completion is associated with longer survival in patients with Mycobacterium avium complex pulmonary disease

JY Kim, JW Park, Y Choi, TS Kim, N Kwak, JJ Yim - Chest, 2023 - Elsevier
Background Morbidity and mortality from nontuberculous mycobacterial pulmonary disease
(NTM-PD) are increasing. Mycobacterium avium complex (MAC) is the most common cause …

Outcomes of adjunctive surgery in patients with nontuberculous mycobacterial pulmonary disease: a systematic review and meta-analysis

JY Kim, HW Lee, JJ Yim, N Kwak - Chest, 2023 - Elsevier
Background The burden of nontuberculous mycobacterial pulmonary disease (NTM-PD) is
increasing worldwide. Amidst the poor treatment success of antibiotic therapy, adjunctive …

Lobectomy for suspected lung cancer without prior diagnosis

MT Onwugbufor, ML Soni, JD Predina, S Knoll… - The Annals of thoracic …, 2023 - Elsevier
Background We describe use, patients, and outcome of diagnostic lobectomy for suspected
lung cancer without pathologic confirmation. Methods A retrospective review of consecutive …

Managing antibiotic resistance in nontuberculous mycobacterial pulmonary disease: challenges and new approaches

YS Kwon, CL Daley, WJ Koh - Expert Review of Respiratory …, 2019 - Taylor & Francis
Introduction: The incidence and prevalence rates of nontuberculous mycobacterial (NTM)
pulmonary disease have been continuously increasing worldwide. However, the rate of …

Non-tuberculous mycobacteria pulmonary disease: A review of trends, risk factors, diagnosis and management

L Nqwata, AR Ouédrago - African Journal of Thoracic and Critical …, 2022 - journals.co.za
Non-tuberculous mycobacteria (NTM) reports have been on the rise globally, with increasing
incidence and prevalence accompanied by poor outcomes. The rise has been attributed to …

[HTML][HTML] Quantitative assessment of erector spinae muscles in patients with Mycobacterium avium complex lung disease

T Asakura, Y Yamada, S Suzuki, H Namkoong… - Respiratory …, 2018 - Elsevier
Background and objective No reports exist regarding skeletal muscle involvement in
patients with Mycobacterium avium complex lung disease (MAC-LD). The cross-sectional …